Tag

Unitedhealth

All articles tagged with #unitedhealth

UnitedHealth to Slash Pre-Authorization Hurdle with AI-Driven Approvals
business26 days ago

UnitedHealth to Slash Pre-Authorization Hurdle with AI-Driven Approvals

UnitedHealth said it will stop requiring approvals for a range of tests, surgeries and therapies, using AI to automate or eliminate prior authorizations for items like echocardiograms and certain outpatient services. The move aims to cut required authorizations by nearly a third this year and speed access to care, noting that prior authorizations currently apply to about 2% of services and most approvals occur within 24 hours. The policy shift signals how AI could reshape the financial side of healthcare across Medicare, Medicaid and employer plans.

Morgan Stanley Upgrades UNH Ahead of Earnings on Margin and AI Upside
market-news1 month ago

Morgan Stanley Upgrades UNH Ahead of Earnings on Margin and AI Upside

Morgan Stanley upgrades UnitedHealth (UNH) to Top Pick ahead of its Q1 results, citing clearer Medicare Advantage rate guidance, ongoing MA margin improvement, an Optum Health turnaround, and potential AI-driven efficiencies. A Q1 miss or beat is expected to be largely in line with expectations, with analysts eyeing tangible margin gains in 2027–2028 and a stronger stock trajectory if results align. The firm’s price target is $375 amid a broader Street consensus of Strong Buy with roughly 13% 12‑month upside.

UnitedHealth Stock Dips as Goldman Sees 2026 EPS Path On Track
business4 months ago

UnitedHealth Stock Dips as Goldman Sees 2026 EPS Path On Track

Despite a Q4 EBIT shortfall driven by weaker Optum Health margins and higher opex, Goldman Sachs maintains a Buy rating on UnitedHealth with a $421 target and says the 2026 EPS guidance of $17.75+ is on track with Street expectations. The analyst notes margin improvements in Optum (about 5.1%) and a company-wide operating margin guide of ~3.2%, amid Medicare funding pressure. The stock has fallen roughly 20% to around $282 and sits near a 52-week low, though the note emphasizes the path to margin recovery and long-term upside.

UnitedHealth Sees 2026 Revenue Decline Amid Turnaround Plan
business4 months ago

UnitedHealth Sees 2026 Revenue Decline Amid Turnaround Plan

UnitedHealth beat Q4 earnings modestly ($2.11 vs. $2.10) but issued soft 2026 revenue guidance of just over $439 billion (about a 2% decline from 2025) due to divestitures, a planned U.S. membership reduction, and a roughly $6 billion revenue hit from Medicare’s new V28 coding system. The company aims a domestic-focused turnaround with higher prices, trimmed benefits, and transparency, targeting a 2026 medical benefit ratio of about 88.8% (around 50 bps wide of error), improving from 89.1% in 2025.

Bernstein names UnitedHealth as 2026's top healthcare pick
markets4 months ago

Bernstein names UnitedHealth as 2026's top healthcare pick

Bernstein analyst Lance Wilkes designates UnitedHealth Group (UNH) as his top healthcare stock for 2026, keeping an Outperform rating with a $444 target as margins in Medicare Advantage/Medicaid are expected to recover. He expects earnings growth to resume as UNH exits unprofitable businesses and weighs the potential separation of UnitedHealthcare and Optum, with Optum viewed as a long‑term growth driver. Bernstein sees roughly 33% upside from current levels, while the broader market consensus remains bullish with a target near $398 (~19% upside).

UnitedHealth Boosts Earnings and Guidance Amid Cost Management
business7 months ago

UnitedHealth Boosts Earnings and Guidance Amid Cost Management

UnitedHealth Group beat earnings expectations with a $2.92 EPS but missed revenue targets and saw a 50% drop in operating income, driven by challenges in managing medical costs and Medicare funding. The company's UnitedHealthcare segment grew strongly, while Optum's growth slowed, raising concerns about future margins. Despite raising full-year guidance, cautious outlooks remain as management navigates ongoing headwinds, with shares rising pre-market on positive earnings and Berkshire Hathaway's new investment.